Expression characteristics of serum exosomal microRNAs in patients with liver injury induced by anti-tuberculosis drugs
Quick Facts
- Publication title: Expression characteristics of serum exosomal microRNAs in patients with liver injury induced by anti-tuberculosis drugs
- Journal: Acta Biochim Biophys Sin (Shanghai)
- Year: 2026
- DOI: 10.3724/abbs.2025242
- PMID/PMCID: 41656990; PMC13191468
Research overview
This peer-reviewed publication presents research in Liver & Gastrointestinal and Regenerative Medicine. Its research topic is reflected in the title: "Expression characteristics of serum exosomal microRNAs in patients with liver injury induced by anti-tuberculosis drugs."
Echo Biotech Role
Echo Biotech contributed EV isolation and purification, EV characterization, miRNA profiling/sequencing and bioinformatic analysis; the study also used or cited Exosupur®.
Related platforms: Exoomics®, Research Reagents & Tools
Related services and capabilities: Biofluid EV Isolation & Purification, EV Basic Characterization (TEM/NTA/WB), EV miRNA Profiling / Sequencing, Research Reagent / Product Supply
Related products or reagents: Exosupur® EV Isolation/Purification Kit
References
Original publication: Expression characteristics of serum exosomal microRNAs in patients with liver injury induced by anti-tuberculosis drugs Acta biochimica et biophysica Sinica. 2026. DOI: 10.3724/abbs.2025242. PMID/PMCID: 41656990; PMC13191468.